TME PHARM.CONF.IPO EO 1- Defensive Interval Ratio
TME PHARM.CONF.IPO EO 1- defensive interval ratio. TME PHARM.CONF.IPO EO 1- (0N6A) has a Defensive Interval Ratio of 1 days as of December 2025. Defensive assets of €6.00K (cash €-, short-term investments €4.00K, receivables €2.00K) cover 1 days of daily cash needs of €10.19K/day. See working capital to net assets of TME PHARM.CONF.IPO EO 1- to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of TME PHARM.CONF.IPO EO 1- (2021–2025)
Defensive interval ratio of TME PHARM.CONF.IPO EO 1- from 2021 to 2025. This chart shows how TME PHARM.CONF.IPO EO 1-'s Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1 days, meaning defensive assets of €6.00K can fund 1 days of operations without new revenue. Check 0N6A financial resilience to evaluate the company's liquid asset resilience ratio.
TME PHARM.CONF.IPO EO 1- Defensive Interval Ratio by Year (2021–2025)
TME PHARM.CONF.IPO EO 1- defensive interval ratio by year from 2021 to 2025. The table below presents the year-by-year Defensive Interval Ratio for TME PHARM.CONF.IPO EO 1- from 2021 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see how large is TME PHARM.CONF.IPO EO 1-'s balance sheet.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1 days | €6.00K | €10.19K/day | €- | €4.00K | ▼ 0 days |
| 2024 | 1 days | €5.00K | €4.91K/day | €- | €5.00K | ▼ -1 days |
| 2021 | 2 days | €28.00K | €14.43K/day | €- | €28.00K | — |